cloudfront

Report Detail



Pharma & HealthcareGlobal Human Rabies Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414271
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 123 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Human Rabies Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Human Rabies Vaccines Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Vero Cell Rabies Vaccine
  • 1.2.2 BHK
  • 1.2.3 Chick Embryo Cell Rabies Vaccine
  • 1.2.4 Others
  • 1.3 Market Analysis by Applications
  • 1.3.1 Pre-Exposure Prophylaxis
  • 1.3.2 Post-Exposure Prophylaxis
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Sanofi Pasteur,Inc.
    • 2.1.1 Business Overview
  • 2.1.2 Human Rabies Vaccines Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Sanofi Pasteur,Inc. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Novartis Vaccines and Diagnostics Ltd.
  • 2.2.1 Business Overview
  • 2.2.2 Human Rabies Vaccines Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Cadila Pharmaceuticals Ltd.
  • 2.3.1 Business Overview
  • 2.3.2 Human Rabies Vaccines Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 GlaxoSmithKline Biologicals
  • 2.4.1 Business Overview
  • 2.4.2 Human Rabies Vaccines Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Merck&Co Inc.
  • 2.5.1 Business Overview
  • 2.5.2 Human Rabies Vaccines Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Merck&Co Inc. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Wyeth pharmaceuticals
  • 2.6.1 Business Overview
  • 2.6.2 Human Rabies Vaccines Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Berna Biotech Ltd.
  • 2.7.1 Business Overview
  • 2.7.2 Human Rabies Vaccines Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Berna Biotech Ltd. Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Medimmune LLC
  • 2.8.1 Business Overview
  • 2.8.2 Human Rabies Vaccines Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Medimmune LLC Human Rabies Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Human Rabies Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Human Rabies Vaccines Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Human Rabies Vaccines Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Human Rabies Vaccines Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Human Rabies Vaccines Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Human Rabies Vaccines Market Analysis by Regions

    • 4.1 Global Human Rabies Vaccines Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Human Rabies Vaccines Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Human Rabies Vaccines Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 4.3 Europe Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 4.5 South America Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 5 North America Human Rabies Vaccines by Countries

    • 5.1 North America Human Rabies Vaccines Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 5.3 Canada Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 6 Europe Human Rabies Vaccines by Countries

    • 6.1 Europe Human Rabies Vaccines Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 6.3 UK Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 6.4 France Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 6.5 Russia Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 6.6 Italy Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Human Rabies Vaccines by Countries

    • 7.1 Asia-Pacific Human Rabies Vaccines Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 7.3 Japan Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 7.4 Korea Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 7.5 India Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 8 South America Human Rabies Vaccines by Countries

    • 8.1 South America Human Rabies Vaccines Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Human Rabies Vaccines by Countries

    • 9.1 Middle East and Africa Human Rabies Vaccines Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Human Rabies Vaccines Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Human Rabies Vaccines Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 9.3 UAE Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Human Rabies Vaccines Sales and Growth Rate (2013-2018)
  • 10 Global Human Rabies Vaccines Market Segment by Type

    • 10.1 Global Human Rabies Vaccines Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Human Rabies Vaccines Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Human Rabies Vaccines Revenue and Market Share by Type (2013-2018)
  • 10.2 Vero Cell Rabies Vaccine Sales Growth and Price
  • 10.2.1 Global Vero Cell Rabies Vaccine Sales Growth (2013-2018)
  • 10.2.2 Global Vero Cell Rabies Vaccine Price (2013-2018)
  • 10.3 BHK Sales Growth and Price
  • 10.3.1 Global BHK Sales Growth (2013-2018)
  • 10.3.2 Global BHK Price (2013-2018)
  • 10.4 Chick Embryo Cell Rabies Vaccine Sales Growth and Price
  • 10.4.1 Global Chick Embryo Cell Rabies Vaccine Sales Growth (2013-2018)
  • 10.4.2 Global Chick Embryo Cell Rabies Vaccine Price (2013-2018)
  • 10.5 Others Sales Growth and Price
  • 10.5.1 Global Others Sales Growth (2013-2018)
  • 10.5.2 Global Others Price (2013-2018)
  • 11 Global Human Rabies Vaccines Market Segment by Application

    • 11.1 Global Human Rabies Vaccines Sales Market Share by Application (2013-2018)
    • 11.2 Pre-Exposure Prophylaxis Sales Growth (2013-2018)
    • 11.3 Post-Exposure Prophylaxis Sales Growth (2013-2018)

    12 Human Rabies Vaccines Market Forecast (2018-2023)

    • 12.1 Global Human Rabies Vaccines Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Human Rabies Vaccines Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Human Rabies Vaccines Market Forecast (2018-2023)
  • 12.2.2 Europe Human Rabies Vaccines Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Human Rabies Vaccines Market Forecast (2018-2023)
  • 12.2.4 South America Human Rabies Vaccines Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Human Rabies Vaccines Market Forecast (2018-2023)
  • 12.3 Human Rabies Vaccines Market Forecast by Type (2018-2023)
  • 12.3.1 Global Human Rabies Vaccines Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Human Rabies Vaccines Market Share Forecast by Type (2018-2023)
  • 12.4 Human Rabies Vaccines Market Forecast by Application (2018-2023)
  • 12.4.1 Global Human Rabies Vaccines Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Human Rabies Vaccines Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.

      Scope of the Report:

      This report focuses on the Human Rabies Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Global human rabies vaccines market is expected to witness robust growth over the forecast period. Increasing global incidences of mortality due to rabies, growing issue of stray dogs in countries with low economic development, rising number of pets, lack of pet management services, low immunization rates in pets, and rising friendliness with pets are drivers estimated to boost growth of human rabies vaccine market.

      The worldwide market for Human Rabies Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers

      Sanofi Pasteur,Inc.

      Novartis Vaccines and Diagnostics Ltd.

      Cadila Pharmaceuticals Ltd.

      GlaxoSmithKline Biologicals

      Merck&Co Inc.

      Wyeth pharmaceuticals

      Berna Biotech Ltd.

      Medimmune LLC

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Vero Cell Rabies Vaccine

      BHK

      Chick Embryo Cell Rabies Vaccine

      Others

      Market Segment by Applications, can be divided into

      Pre-Exposure Prophylaxis

      Post-Exposure Prophylaxis

      There are 15 Chapters to deeply display the global Human Rabies Vaccines market.

      Chapter 1, to describe Human Rabies Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Human Rabies Vaccines, with sales, revenue, and price of Human Rabies Vaccines, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Rabies Vaccines, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Human Rabies Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Human Rabies Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Human Rabies Vaccines . Industry analysis & Market Report on Human Rabies Vaccines is a syndicated market report, published as Global Human Rabies Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Human Rabies Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report